127 related articles for article (PubMed ID: 21194789)
1. Effectiveness of a new decolonisation regimen for eradication of extended-spectrum β-lactamase-producing Enterobacteriaceae.
Buehlmann M; Bruderer T; Frei R; Widmer AF
J Hosp Infect; 2011 Feb; 77(2):113-7. PubMed ID: 21194789
[TBL] [Abstract][Full Text] [Related]
2. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation.
Tschudin-Sutter S; Frei R; Dangel M; Stranden A; Widmer AF
Clin Infect Dis; 2012 Dec; 55(11):1505-11. PubMed ID: 22955436
[TBL] [Abstract][Full Text] [Related]
3. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
Strenger V; Gschliesser T; Grisold A; Zarfel G; Feierl G; Masoud L; Hoenigl M; Resch B; Müller W; Urlesberger B
Int J Antimicrob Agents; 2011 Jan; 37(1):67-9. PubMed ID: 21074372
[TBL] [Abstract][Full Text] [Related]
4. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period.
Kola A; Holst M; Chaberny IF; Ziesing S; Suerbaum S; Gastmeier P
J Hosp Infect; 2007 May; 66(1):46-51. PubMed ID: 17350720
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden.
Ostholm-Balkhed A; Tärnberg M; Nilsson M; Johansson AV; Hanberger H; Monstein HJ; Nilsson LE
Scand J Infect Dis; 2010 Dec; 42(11-12):831-8. PubMed ID: 20608768
[TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.
Moor CT; Roberts SA; Simmons G; Briggs S; Morris AJ; Smith J; Heffernan H
J Hosp Infect; 2008 Apr; 68(4):355-62. PubMed ID: 18353497
[TBL] [Abstract][Full Text] [Related]
7. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].
Bayraktar B; Toksoy B; Bulut E
Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
9. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
Kader AA; Kumar AK
Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Chiu S; Huang YC; Lien RI; Chou YH; Lin TY
Acta Paediatr; 2005 Nov; 94(11):1644-9. PubMed ID: 16303704
[TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study.
Demir S; Soysal A; Bakir M; Kaufmann ME; Yagci A
J Paediatr Child Health; 2008 Oct; 44(10):548-53. PubMed ID: 18557808
[TBL] [Abstract][Full Text] [Related]
13. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
[TBL] [Abstract][Full Text] [Related]
14. Extended-spectrum beta-lactamase-producing Enterobacteriaceae at Middlemore Hospital.
Briggs S; Ussher J; Taylor S
N Z Med J; 2005 Jul; 118(1218):U1563. PubMed ID: 16027752
[TBL] [Abstract][Full Text] [Related]
15. Colonisation by extended-spectrum beta-lactamase-producing Klebsiella spp. in a paediatric intensive care unit.
Levy SS; Mello MJ; Gusmão-Filho FA; Correia JB
J Hosp Infect; 2010 Sep; 76(1):66-9. PubMed ID: 20621392
[TBL] [Abstract][Full Text] [Related]
16. [Five years follow-up of infections with extended-spectrum beta-lactamase producing enterobacteriaceae].
Fouquet M; Morange V; Bruyère F
Prog Urol; 2012 Jan; 22(1):17-21. PubMed ID: 22196001
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors for colonisation with extended spectrum beta-lactamase producing enterobacteriacae vis-à-vis usage of antimicrobials.
Sarma JB; Ahmed GU
Indian J Med Microbiol; 2010; 28(3):217-20. PubMed ID: 20644309
[TBL] [Abstract][Full Text] [Related]
18. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.
Reddy P; Malczynski M; Obias A; Reiner S; Jin N; Huang J; Noskin GA; Zembower T
Clin Infect Dis; 2007 Oct; 45(7):846-52. PubMed ID: 17806048
[TBL] [Abstract][Full Text] [Related]
19. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Huang SS; Lee MH; Leu HS
J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
